Related Experiment Video
Updated: Sep 30, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The development of end stage renal disease in two patients with PMM2-CDG
Henna Tiwary1, Leah E Hecht1, William J Brucker2
1Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA.
Abstract:
We report two patients with PMM2-CDG who developed end stage renal disease (ESRD). Renal abnormalities of clinical significance have only been reported in about 6% of patients with PMM2-CDG and have rarely been reported as the cause of death. Given the recurrent episodes of acute kidney injury associated with hospital admissions and the accelerated development of ESRD thereafter in our two patients, we recommend proactively involving Nephrology early in the care of these patients.
Insights
Two patients with PMM2-CDG developed end-stage renal disease (ESRD). Early nephrology consultation is recommended for PMM2-CDG patients due to the risk of acute kidney injury and accelerated ESRD progression.
Area of Science:
- Biochemistry
- Genetics
- Nephrology
Background:
- Phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG) is a rare genetic disorder.
- Renal abnormalities are infrequently reported in PMM2-CDG patients.
Observation:
- Two patients with PMM2-CDG experienced recurrent acute kidney injury.
- These episodes led to accelerated progression to end-stage renal disease (ESRD).
Findings:
- End-stage renal disease (ESRD) is a rare but severe complication of PMM2-CDG.
- The observed cases suggest a potential link between PMM2-CDG and progressive kidney damage.
Implications:
- Proactive nephrology involvement is crucial for managing PMM2-CDG patients.
- Early intervention may mitigate the risk of acute kidney injury and slow ESRD progression.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Peritoneal Dialysis III: Nursing Management

